Morgan Stanley
SBFM

Morgan Stanley’s Sunshine Biopharma SBFM Stock Holding History

Morgan Stanley’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.2K Hold
1,463
– – ﹤0.01% 6823
2025
Q4 		$18K Buy
1,463
+1,080
+282% +$17.1K ﹤0.01% 6725
2025
Q3 		$5.71K Hold
383
– – ﹤0.01% 7057
2025
Q2 		$5.52K Hold
383
– – ﹤0.01% 7010
2025
Q1 		$7.32K Sell
383
-381
-50% -$9.58K ﹤0.01% 6895
2024
Q4 		$22.9K Buy
+764
New +$21.8K ﹤0.01% 6529
2024
Q3 		– Sell
-5
Closed -$213 – 7903
2024
Q2 		$418 Buy
+5
New +$2.38K ﹤0.01% 7246
2024
Q1 		– Hold
0
– – – 7947
2023
Q4 		– Hold
0
– – – 7900
2023
Q3 		– Hold
0
– – – 7570
2023
Q2 		– Hold
0
– – – 7594
2023
Q1 		– Hold
0
– – – 7643
2022
Q3 		– Hold
0
– -$7K – 7847
2022
Q2 		– Hold
0
– – – 7326

Other funds holding SBFM

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Morgan Stanley's SBFM Position: Q1 2026 in Review

Morgan Stanley held its Sunshine Biopharma (SBFM) position steady in Q1 2026 at 1,463 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6823.

Morgan Stanley first reported a position in SBFM in Q2 2024 and has held it in 7 quarters since. The position peaked at $22.9K in Q4 2024. 8 funds tracked by Wall St. Rank hold SBFM as of Q1 2026.

  • Morgan Stanley held 1,463 shares of Sunshine Biopharma worth $15.2K as of Q1 2026.
  • Morgan Stanley left its Sunshine Biopharma share count unchanged in Q1 2026.
  • Sunshine Biopharma made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6823 holding.
  • Morgan Stanley first reported a position in Sunshine Biopharma in Q2 2024 and has held it in 7 quarters since.
  • Morgan Stanley's Sunshine Biopharma position peaked at $22.9K in Q4 2024.
  • 8 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.